Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy

Oral Oncology

Volumn 46, Issue 10, 2010, Pages 705-711

  Ihloff, A S ^a   Petersen, C ^a   Hoffmann, M ^b   Knecht, R ^a   Tribius, S ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Chemoradiotherapy; Clinical trials; Human papillomavirus; Locally advanced; Oral oncology; Oropharyngeal cancer

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; NIMORAZOLE; PACLITAXEL; PLACEBO; TIRAPAZAMINE; VORINOSTAT;

ADVANCED CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER SURGERY; CLINICAL STUDY; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; HIGH RISK PATIENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MULTIPLE CYCLE TREATMENT; NONHUMAN; OROPHARYNX CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; QUALITY OF LIFE; REVIEW; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX; SURVIVAL RATE; TREATMENT RESPONSE; VIRUS INFECTION; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS AS TOPIC; DNA, VIRAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS;

EID: 77957344295     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.07.006     Document Type: Review

References (52)

1. T. Andl, T. Kahn, and A. Pfuhl Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control Cancer Res 58 1998 5 13
2. M.L. Gillison, W.M. Koch, and R.B. Capone Evidence for a causal association between human papillomavirus and a subset of head and neck cancers J Natl Cancer Inst 92 2000 709 720
3. A. Psyrri, L. Prezas, and B. Burtness Oropharyngeal cancer Clin Adv Hematol Oncol 6 2008 604 612
4. G. D'Souza, A.R. Kreimer, and R. Viscidi Case-control study of human papillomavirus and oropharyngeal cancer N Engl J Med 356 2007 1944 1956
5. P.M. Weinberger, Z. Yu, and B.G. Haffty Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis J Clin Oncol 24 2006 736 747
6. J.P. Klussmann, S.J. Weissenborn, and U. Wieland Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas Cancer 92 2001 2875 2884
7. A.K. Chaturvedi, E.A. Engels, W.F. Anderson, and M.L. Gillison Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States J Clin Oncol 26 2008 612 619
8. L. Hammarstedt, H. Dahlstrand, and D. Lindquist The incidence of tonsillar cancer in Sweden is increasing Acta Otolaryngol 127 2007 988 992
9. Marur S, D'Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010 May 5. [Epub ahead of print].
10. T. Wiest, E. Schwarz, C. Enders, C. Flechtenmacher, and F.X. Bosch Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control Oncogene 21 2002 1510 1517
11. S. Duensing, and K. Münger Centrosome abnormalities and genomic instability induced by human papillomavirus oncoproteins Prog Cell Cycle Res 5 2003 383 391
12. M. Gillison Human papillomavirus and oropharyngeal cancer. Author reply N Engl J Med 357 2007 1157 1158
13. M. Nasseri, J.R. Gage, A. Lorincz, and F.O. Wettstein Human papillomavirus type 16 immortalized cervical keratinocytes contain transcripts encoding E6, E7, and E2 initiated at the P97 promoter and express high levels of E7 Virology 184 1991 131 140
14. P.M. Howley Role of the human papillomaviruses in human cancer Cancer Res 51 18 Suppl. 1991 5019s 5022s
15. T. Crook, J.P. Morgenstern, L. Crawford, and L. Banks Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ- ras EMBO J 8 1989 513 519
16. INK4a overexpression predicts translational active human papillomavirus infection in tonsillar cancer. Int J Cancer 2010 Jan 20 [Epub ahead of print].
17. P.K. Goon, M.A. Stanley, and J. Ebmeyer HPV & head and neck cancer: a descriptive update Head Neck Oncol 1 2009 36
18. L. Licitra, F. Perrone, and P. Bossi High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma J Clin Oncol 24 2006 5630 5636
19. N. Reimers, H.U. Kasper, and S.J. Weissenborn Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer Int J Cancer 120 2007 1731 1738
20. Adelstein DJ, Ridge JA, Gillison ML, et al. Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, DC, Head Neck, vol. 31; 2009. p. 1393-1422.
21. L. Licitra, and E. Felip Squamous cell carcinoma of the head and neck: ESMO clinical recommendations for diagnosis, treatment and follow up Ann Oncol 20 Suppl. 4 2009 iv121 iv122
22. National Comprehensive Cancer Network. Practice guidelines in oncology: Head and neck cancers v.1.2009. .
23. M. Haigentz Jr., C.E. Silver, and J. Corry Current trends in initial management of oropharyngeal cancer: the declining use of open surgery Eur Arch Otorhinolaryngol 266 2009 1845 1855
24. W.L. Hicks Jr., M.A. Kuriakose, and T.R. Loree Surgery versus radiation therapy as single-modality treatment of tonsillar fossa carcinoma: The Roswell Park Cancer Institute experience (1971-1991) Laryngoscope 108 1998 1014 1019
25. G. Calais, M. Alfonsi, and E. Bardet Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma J Natl Cancer Inst 91 1999 2081 2086
26. F. Denis, P. Garaud, and E. Bardet Final results of the 94-01 French head and neck oncology and radiotherapy group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma J Clin Oncol 22 2004 69 76
27. J.S. Cooper, K. Fu, J. Marks, and S. Silverman Late effects of radiation therapy in the head and neck region Int J Radiat Oncol Biol Phys 31 1995 1141 1164
28. J. Bernier, C. Domenge, and M. Ozsahin Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 350 2004 1945 1952 (Pubitemid 38580197)
29. J.S. Cooper, T.F. Pajak, and A.A. Forastiere Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 350 2004 1937 1944
30. T.Y. Seiwert, and E.E. Cohen State-of-the-art management of locally advanced head and neck cancer Br J Cancer 92 2005 1341 1348
31. J.M. Bumpous Surgical salvage of cancer of the oropharynx after chemoradiation Curr Oncol Rep 11 2009 151 155
32. R.P. Morton Studies in the quality of life of head and neck cancer patients: results of a two-year longitudinal study and a comparative cross-sectional cross-cultural survey Laryngoscope 113 2003 1091 1103
33. S. Laverick, D. Lowe, J.S. Brown, E.D. Vaughan, and S.N. Rogers The impact of neck dissection on health-related quality of life Arch Otolaryngol Head Neck Surg 130 2004 149 154
34. A. de Graeff, J.R. de Leeuw, W.J. Ros, G.J. Hordijk, G.H. Blijham, and J.A. Winnubst A prospective study on quality of life of patients with cancer of the oral cavity or oropharynx treated with surgery with or without radiotherapy Oral Oncol 35 1999 27 32
35. P. Infante-Cossio, E. Torres-Carranza, A. Cayuela, E. Hens-Aumente, P. Pastor-Gaitan, and J.L. Gutierrez-Perez Impact of treatment on quality of life for oral and oropharyngeal carcinoma Int J Oral Maxillofac Surg 38 2009 1052 1058
36. P. Boscolo-Rizzo, M. Stellin, R. Fuson, C. Marchiori, A. Gava, and M.C. Da Mosto Long-term quality of life after treatment for locally advanced oropharyngeal carcinoma: surgery and postoperative radiotherapy versus concurrent chemoradiation Oral Oncol 45 2009 953 957
37. F.P. Worden, B. Kumar, and Lee JS Wolf Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: Response and survival positively associated with HPV16 copy number J Clin Oncol 26 2008 3138 3146
38. B. Kumar, K.G. Cordell, and J.S. Lee EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer J Clin Oncol 26 2008 3128 3137
39. C. Fakhry, W.H. Westra, and S. Li Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial J Natl Cancer Inst 100 2008 261 269
40. S. Jo, A. Juhasz, and K. Zhang Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial Anticancer Res 29 2009 1467 1474
41. M.S. Kies, F.C. Holsinger, and J.J. Lee Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial J Clin Oncol 28 2010 8 14
42. K. Settle, M.R. Posner, and L.M. Schumaker Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients Cancer Prev Res (Phila Pa) 2 2009 776 781
43. D. Rischin, L. Peters, and B. O'Sullivan Trans-tasman radiation oncology group phase III study of tirapazamine, cisplatin and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck J Clin Oncol 26 15S 2008 [Abstract LBA6008]
44. Ang AK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010 June 7. [Epub ahead of print].
45. INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck J Clin Oncol 27 2009 1992 1998
46. P. Lassen, J.G. Eriksen, and S. Hamilton-Dutoit HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer Radiother Oncol 94 2010 30 35
47. J.H. Maxwell, B. Kumar, and F.Y. Feng Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence Clin Cancer Res 16 2010 1226 1235
48. L.J. Peters, B. O'Sullivan, and J. Giralt Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02 02 J Clin Oncol 28 2010 2996 3001
49. A. Obata, M. Eura, and J. Sasaki Clinical significance of p53 functional loss in squamous cell carcinoma of the oropharynx Int J Cancer 89 2000 187 193
50. T.L. DeWeese, and J.C. Walsh Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation Int J Radiat Oncol Biol Phys 37 1997 145 154
51. R.L. Ferris, I. Martinez, and N. Sirianni Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis Eur J Cancer 41 2005 807 815
52. M. Zimmermann, A. Zouhair, D. Azria, and M. Ozsahin The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications Radiat Oncol 1 2006 11